US FY27 Drug Transit Country Determination
Analysis based on 16 articles · First reported Sep 16, 2026 · Last updated Sep 17, 2026
The determination is largely a routine annual regulatory designation and is unlikely to move broad equity or currency markets, though it keeps pharmaceutical supply-chain and precursor-chemical trade compliance in focus. Companies exposed to US-India and US-China pharmaceutical and chemical supply chains may face marginally higher scrutiny, while the absence of a failed-demonstrably designation for India and China limits any punitive trade or aid consequences.
US President Donald Trump submitted a Presidential Determination to the United States — United States Congress on September 15, 2026, naming 23 countries as major drug transit or major illicit drug-producing countries for fiscal year 2027. The list, released publicly by the United States — United States Department of State on September 16, includes India, China, Pakistan, Afghanistan, Mexico, Colombia, Myanmar, Venezuela, Bolivia, Peru and several Latin American and Caribbean states. Trump welcomed the efforts of Prime Minister Narendra Modi and the Government of India to curb illicit opium poppy cultivation and bolster supply chain integrity, and said he looked forward to continued cooperation under the United States-India Drug Policy Framework. India, China and Pakistan were not designated as having failed demonstrably to meet international counternarcotics obligations. That separate designation was applied to Afghanistan, Bolivia, Myanmar and Colombia, while Venezuela was removed from it. Trump pressed China over its role as the world's largest producer of precursor chemicals used to make fentanyl, methamphetamine and other synthetic drugs, noting he had raised the issue directly with President Xi Jinping and that Beijing had implemented licensing requirements for exporters of designated precursor chemicals to North America. He also urged Canada and Mexico to strengthen efforts against cross-border drug trafficking and narcoterrorist organizations. US ambassador to India Sergio Gor applauded Modi's anti-drug efforts. Trump cited tighter border security, reduced seizures and falling overdose deaths as evidence of progress.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard